EUVIMEDEUVIMED entdecken
Open Access

Role of Bevacizumab in Multiple Glioblastomas: A Retrospective Single-Center Analysis

Yongrui Zhao, Yidong Chen, Leiming Wang, Ye Cheng, Feng Yan, Jiankun Xu iD

Neurosciences · 30.04.2026 · 31 (2) · 181-188

DOI: 10.17712/1658-3183.2795 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurosciences, online erschienen am 30.04.2026. Verfasst von Yongrui Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Beijing Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, Chin…. Hauptthemen laut MEDLINE: Bevacizumab, Glioblastoma, Brain Neoplasms, Antineoplastic Agents, Immunological. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To explore the prognostic factors of multiple glioblastomas (M-GBMs) and the role of bevacizumab (BEV) in M-GBMs.

Methods

162 patients treated for primary glioblastoma (GBM) from 2020 to 2024 were retrospectively reviewed. Kaplan–Meier analysis was performed to compare progression-free survival (PFS) and overall survival (OS) between the single glioblastoma (S-GBM) group and the M-GBMs group. Independent predictors of OS among M-GBMs patients were evaluated via multivariable Cox regression analysis.

Results

116 patients had S-GBM, and 46 had M-GBMs. Compared with S-GBM patients, M-GBMs patients had poorer PFS (6.5 vs. 11 months, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BevacizumabGlioblastomaBrain NeoplasmsAntineoplastic Agents, ImmunologicalHumansRetrospective StudiesFemaleMaleMiddle AgedAdultAgedPrognosis

Stichwörter der Autor:innen

BevacizumabGlioblastomaMulticentricMultifocalMultiple

Substanzen

BevacizumabAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Department of Radiation Oncology, Beijing Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Department of Pathology, Beijing Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Department of Neurosurgery, Beijing Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Jiankun Xu

Zitieren

APA

Zhao, Y., Chen, Y., Wang, L., Cheng, Y., Yan, F., & Xu, J. (2026). Role of Bevacizumab in Multiple Glioblastomas: A Retrospective Single-Center Analysis. Neurosciences, 31(2), 181-188. https://doi.org/10.17712/1658-3183.2795

Vancouver

Zhao Y, Chen Y, Wang L, Cheng Y, Yan F, Xu J. Role of Bevacizumab in Multiple Glioblastomas: A Retrospective Single-Center Analysis. Neurosciences. 2026;31(2):181-188. doi:10.17712/1658-3183.2795

BibTeX
@article{Zhao2026,
  author = {Zhao, Yongrui and Chen, Yidong and Wang, Leiming and Cheng, Ye and Yan, Feng and Xu, Jiankun},
  title = {Role of Bevacizumab in Multiple Glioblastomas: A Retrospective Single-Center Analysis},
  journal = {Neurosciences},
  year = {2026},
  volume = {31},
  number = {2},
  pages = {181--188},
  doi = {10.17712/1658-3183.2795}
}
Kostenlos starten →